Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026

Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026 GlobeNewswire January 06, 2026 Completed enrollment in DENALI Part 2a; dose confirmation expected in 1H 2026 DENALI Part 2 trial topline readout expected by year end 2026; potential to support accelerated approval Initiation of the ASPENOVA […]

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S. Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque Analysis GlobeNewswire January 06, 2026 MOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI

Brane Audio Unveils RAD2 at CES 2026: The Next Major Advancement in Sub-Bass Technology

Brane Audio Unveils RAD2 at CES 2026: The Next Major Advancement in Sub-Bass Technology RAD2 delivers a 30-fold advantage in deep bass sound production and will power the next generation of Brane Audio speakers GlobeNewswire January 06, 2026 Las Vegas, Jan. 06, 2026 (GLOBE NEWSWIRE) — Key Highlights Brane Audio debuts RAD2, the most efficient

Galecto Announces Key Additions to Leadership Team

Galecto Announces Key Additions to Leadership Team GlobeNewswire January 06, 2026 Deep hematology/oncology drug development experience added with the appointment of Sherwin Sattarzadeh as Chief Operating Officer and Becker Hewes as Chief Medical Officer DMR-001, a potentially best-in-class mutant calreticulin (“mutCALR”) targeting monoclonal antibody, on track for IND submission in mid-2026 with anticipated first-in-human dosing

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS) Clinical trial evaluating changes in urine protein-to-creatinine ratio, a widely-accepted endpoint measuring risk reduction of kidney failure GlobeNewswire January 06, 2026 CAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) — Akebia Therapeutics(R), Inc. (Nasdaq: AKBA),

Precision Drilling Meets Annual Capital Allocation Targets and Provides Financial and Operational Updates

Precision Drilling Meets Annual Capital Allocation Targets and Provides Financial and Operational Updates GlobeNewswire January 06, 2026 CALGARY, Alberta, Jan. 06, 2026 (GLOBE NEWSWIRE) — This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For a full disclosure of the forward-looking information and statements and the risks to which

Sow Good Inc. Announces $6.0 Million Private Placement, Strategic Asset Sale, and Leadership Transition to Support Continued Candy Operations and Future Growth

Sow Good Inc. Announces $6.0 Million Private Placement, Strategic Asset Sale, and Leadership Transition to Support Continued Candy Operations and Future Growth GlobeNewswire January 06, 2026 IRVING, Texas, Jan. 06, 2026 (GLOBE NEWSWIRE) — Sow Good Inc. (NASDAQ: SOWG) (“Sow Good” or the “Company”), a leading freeze-dried food and candy manufacturer, today announced the completion

JFB Construction Announces Anticipated 2025 Revenues of $32 million

JFB Construction Announces Anticipated 2025 Revenues of $32 million GlobeNewswire January 06, 2026 Full year 2025 revenues increase 40%as compared with full year 2024 revenues Lantana, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) — JFB Construction Holdings (Nasdaq: JFB), a real estate development and construction company focused on hospitality, commercial, industrial, and residential property development, today

Willis Lease Finance Corporation Establishes New Asset Management Entity, Willis Aviation Capital

Willis Lease Finance Corporation Establishes New Asset Management Entity, Willis Aviation Capital GlobeNewswire January 06, 2026 COCONUT CREEK, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and a global provider of aviation services, today announced the establishment of Willis

HydroGraph and GEIC Expand Collaboration through Tier 1 Membership

HydroGraph and GEIC Expand Collaboration through Tier 1 Membership GlobeNewswire January 06, 2026 MANCHESTER, United Kingdom, Jan. 06, 2026 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph” or the “Company”) and the Graphene Engineering Innovation Centre (GEIC) at The University of Manchester are expanding their collaboration as HydroGraph moves from a

Scroll to Top